AI assistant
Sending…
IMUGENE LIMITED — Director's Dealing 2017
Oct 25, 2017
65124_rns_2017-10-25_da8c41b9-324e-43e6-84c4-b1e037efb9d7.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [155 x 36] intentionally omitted <==
==> picture [438 x 230] intentionally omitted <==
==> picture [180 x 9] intentionally omitted <==
==> picture [271 x 93] intentionally omitted <==
==> picture [374 x 39] intentionally omitted <==
==> picture [399 x 47] intentionally omitted <==
==> picture [415 x 65] intentionally omitted <==
==> picture [323 x 99] intentionally omitted <==
==> picture [46 x 13] intentionally omitted <==
==> picture [359 x 30] intentionally omitted <==
| Dateofchange | Personwhose | Natureof | Consideration | aa=and | Person'svotes |
|---|---|---|---|---|---|
| relevantInterest | change(6) | glven In relation | numberof | affected | |
| changed | to changeM | securltles | |||
| affected | |||||
| 11/04/2017 | Platinum | Acquisitionof | $350,000.01 | ORD23,333,334 | 23,333,334 |
| Investment | shares | ||||
| Management | |||||
| LTD | |||||
| 17/10/2017 | Platinum | Disposalof | $130,224.45 | ORD6,858,136 | 6,858,136 |
| Investment | Shares | ||||
| Mananment | |||||
| LTD | |||||
| 19/10/2017 | Platinum | D&$posalof | $3,690.21 | ORD194,341 | 194 41 |
| Investment | bres | ||||
| Manasement | |||||
| LTD | |||||
| 19/10/2017 | Platinum | Disposalof | $95,938 43 | ORD5,052,726 | 5,052,726 |
| Investment | Shares | ||||
| Manapment | |||||
| LTD | |||||
| 23/10/1017 | Platinum | Disposalof | $230,068.96 | ORD12,116,344 | 120116,344 |
| Investment | Shares | ||||
| Managemem | |||||
| LTD | |||||
| 24/10/2017 | Platinum | Disposalof | $92,802.60 | ORD4,887,353 | 4,887,353 |
| Investment | Shares | ||||
| Mar,a®ement | |||||
| LTD |
More from IMUGENE LIMITED
Regulatory Filings
2026
May 21
Director's Dealing
2026
May 17
Director's Dealing
2026
May 14
Major Shareholding Notification
2026
May 11
Share Issue/Capital Change
2026
May 4
Capital/Financing Update
2026
Apr 30
Capital/Financing Update
2026
Apr 30
Regulatory Filings
2026
Apr 30
Share Issue/Capital Change
2026
Apr 30
Capital/Financing Update
2026
Apr 29